http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MX-2018005358-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cbf2c908f2fd40803aab999897d08ae4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2027
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-606
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2866
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2846
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-606
filingDate 2016-10-21-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d9b460da05b4f033e9676d05f0f86ff
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_96eb86362d39be1b43eeaf514656c5a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d3c2697d188828aece010a63b6a1c55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_883465357b474ffec301708dbe6dba60
publicationDate 2018-06-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber MX-2018005358-A
titleOfInvention COMPRESSED HIGH DOSE CONTAINING OPTIMIZED MESALAZINE.
abstract The present invention relates to an oral gastro-resistant high dose tablet comprising as an active constituent mesalazine as well as the use thereof.
priorityDate 2015-10-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4075
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419534865

Total number of triples: 25.